- Home
- DHY vs OSUR Comparison
DHY vs OSUR Comparison
Compare DHY & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHY
- OSUR
- Stock Information
- Founded
- DHY 1998
- OSUR 2000
- Country
- DHY United States
- OSUR United States
- Employees
- DHY N/A
- OSUR N/A
- Industry
- DHY Finance/Investors Services
- OSUR Medical/Dental Instruments
- Sector
- DHY Finance
- OSUR Health Care
- Exchange
- DHY Nasdaq
- OSUR Nasdaq
- Market Cap
- DHY 213.4M
- OSUR 231.1M
- IPO Year
- DHY N/A
- OSUR 1986
- Fundamental
- Price
- DHY $2.11
- OSUR $3.02
- Analyst Decision
- DHY
- OSUR Hold
- Analyst Count
- DHY 0
- OSUR 1
- Target Price
- DHY N/A
- OSUR $3.00
- AVG Volume (30 Days)
- DHY 569.1K
- OSUR 513.3K
- Earning Date
- DHY 01-01-0001
- OSUR 11-05-2025
- Dividend Yield
- DHY 9.10%
- OSUR N/A
- EPS Growth
- DHY N/A
- OSUR N/A
- EPS
- DHY N/A
- OSUR N/A
- Revenue
- DHY N/A
- OSUR $138,533,000.00
- Revenue This Year
- DHY N/A
- OSUR N/A
- Revenue Next Year
- DHY N/A
- OSUR $4.32
- P/E Ratio
- DHY N/A
- OSUR N/A
- Revenue Growth
- DHY N/A
- OSUR N/A
- 52 Week Low
- DHY $1.77
- OSUR $2.36
- 52 Week High
- DHY $2.08
- OSUR $4.60
- Technical
- Relative Strength Index (RSI)
- DHY 58.47
- OSUR 42.20
- Support Level
- DHY $2.04
- OSUR $3.10
- Resistance Level
- DHY $2.10
- OSUR $3.29
- Average True Range (ATR)
- DHY 0.02
- OSUR 0.11
- MACD
- DHY 0.00
- OSUR -0.03
- Stochastic Oscillator
- DHY 93.75
- OSUR 19.84
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.